I’m enjoying attending and speaking at the annual Science Writers 2018 meeting in D.C. where I spoke this morning on a panel about stem cells. The session was specifically on the Wild West of stem cells. You can follow the meeting events on Twitter with the #sciwri18 hashtag. I had three wonderful fellow panelists, Marilynn Marchione of […]
Highlights of Science Writers DC Stem Cell Panel with FDA’s Peter Marks Read More »
Editors note: This is a guest post from Caroline Simons who is attending the two Paris meetings on human gene editing. For more background on those meetings see here. By Caroline Simons There were just over a hundred participants at the workshop organized by the Federation of European Academies of Medicine, the UK Academy of
Paris human gene editing workshop summary Read More »
How do governance issues for human genome editing work at the international level? Indira Nath, All India Institute of Medical Sciences, gives a nice overview to start the session. She raised the example of medical tourism and surrogacy in India. She argued for an international consensus on what is permissible on human gene editing. How
Live Blog #GeneEditSummit Day 2 Post #2: International Governance Read More »
Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first
Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »
Note that this poll is focused on germline, heritable genetic modification. Thus, it does not include somatic cell/gene therapy applications.
Poll #GeneEditSummit: a moratorium on human genetic modification? Read More »
The Summit on Human Gene Editing got off to a great start yesterday. I have four posts summarizing all the talks and my impressions on the points made (here, here, here, and here). What was the overall gestalt including from talking to people informally? What were the big takeaway messages so far from Day 1? Diverse views.
Human Gene Editing takeaways from day 1 of #GeneEditSummit Read More »
The US National Academy of Sciences (NAS) will hold a meeting on heritable human germline modification on December 1-3, 2015 in Washington, D.C. Invitations to the NAS meeting to individuals starting going out last week. The upcoming NAS meeting seeks to address these issues and discuss the possibility of a moratorium on clinical use of
NAS Meeting on Human Germline Modification Taking Shape Read More »
Last week I attended and spoke at a stem cell meeting at Rensselaer Polytechnic Institute (RPI). It was entitled, “Bioengineering and Stem Cell Research”. It was a great meeting with many interesting talks. Below I write about some of the talks and themes of the meeting. Still to come later this week I will do a second post entirely
Rensselaer Polytechnic Institute stem cell meeting report Read More »
CRISPR Cas9 gene editing technology is a game changer on many levels both inside and soon outside the lab. There is a growing sense of urgency amongst biomedical scientists to take a proactive approach to current and future use of CRISPR gene editing technology in human germ cells and embryos. These concerns have been heightened
Practical Plan for Managing Human Germline CRISPR Read More »
In a new perspectives piece in Science, Nobel Laureate David Baltimore and co-authors including Jennifer Doudna and George Church, chart a potential path forward for human germline engineering. See also accompanying Bioethics piece by Gretchen Vogel as well, “Embryo engineering alarm”. In the piece, entitled “A prudent path forward for genomic engineering and germline gene
David Baltimore, et al. path for human germline engineering Read More »